Search - tctmd.com

Displaying 221 - 240 of 267

Sort: Relevancy | Date

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

News Conference News AHA 2012

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

October 25, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Daily News

El Tratamiento Endovascular del ACV, aunque Poco Común, va Ganando Terreno

Caitlin E. Cox

September 18, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Daily News

CREST: Similar Cost Effectiveness for Carotid Stenting, Surgery

L.A. McKeown

July 25, 2012

News Daily News

CREST: Similar Rentabilidad entre la Colocación de Stents Carotídeos y la Cirugía

L.A. McKeown

July 25, 2012

News Daily News

Meta Análisis: La Terapia Endovascular Mejora los Resultados en Pacientes con ACV Isquémico Agudo

Jason Kahn

July 24, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 10, 2012

News Features

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Yael L. Maxwell

July 09, 2012

News Daily News

Un Cribado del AAA es Bueno para los Hombres y un Nuevo Cribado podría ser incluso Mejor

L.A. McKeown

July 09, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Industry News

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

June 26, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

Advertisement

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Pair of Studies Look at Cost Effectiveness of PCI in Different Populations

Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

El Tratamiento Endovascular del ACV, aunque Poco Común, va Ganando Terreno

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

CREST: Similar Cost Effectiveness for Carotid Stenting, Surgery

CREST: Similar Rentabilidad entre la Colocación de Stents Carotídeos y la Cirugía

Meta Análisis: La Terapia Endovascular Mejora los Resultados en Pacientes con ACV Isquémico Agudo

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Shift in CMS Policy Shines Spotlight on PCI Readmissions

Un Cribado del AAA es Bueno para los Hombres y un Nuevo Cribado podría ser incluso Mejor

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Treatment With Brilinta (Ticagrelor) For 12 Months Is Cost-Effective Versus Generic Clopidogrel, Europe New Data Shows

Rivaroxaban May be Cost-Effective for A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content